The mechanisms of anti-PEG immune response are different in the spleen and the lymph nodes

Size Exclusion of Radioactive Polymers (SERP) informs on the biodegradation of trimethyl chitosan and biodegradable polymer nanoparticles in vitro and in vivo

(2022) Amrita Dikpati et al.   JOURNAL OF CONTROLLED RELEASE

Anti-PEG Antibodies Boosted in Humans by SARS-CoV-2 Lipid Nanoparticle mRNA Vaccine

(2022) Yi Ju et al.   ACS Nano

Innate and adaptive immune responses toward nanomedicines

(2021) Iara Maíra de Oliveira Viana et al.   Acta Pharmaceutica Sinica B

Marginal zone B cells: From housekeeping function to autoimmunity?

(2021) Anna-Karin E. Palm et al.   JOURNAL OF AUTOIMMUNITY

Lipid Nanoparticles—From Liposomes to mRNA Vaccine Delivery, a Landscape of Research Diversity and Advancement

(2021) Rumiana Tenchov et al.   ACS Nano

Isolating Nanoparticles from Complex Biological Media by Immunoprecipitation

(2021) Youcef Chakib Hacene et al.   NANO LETTERS

Anti-PEG antibodies compromise the integrity of PEGylated lipid-based nanoparticles via complement

(2021) Mariona Estapé Senti et al.   JOURNAL OF CONTROLLED RELEASE

Accelerated blood clearance and hypersensitivity by PEGylated liposomes containing TLR agonists

(2021) Camilla Stavnsbjerg et al.   JOURNAL OF CONTROLLED RELEASE

Complement activation by drug carriers and particulate pharmaceuticals: Principles, challenges and opportunities

(2020) S. Moein Moghimi et al.   ADVANCED DRUG DELIVERY REVIEWS

Impact of Pre-Existing or Induced Anti-PEG IgM on the Pharmacokinetics of Peginterferon Alfa-2a (Pegasys) in Mice

(2020) Nehal E. Elsadek et al.   MOLECULAR PHARMACEUTICS

Residual Solvents in Nanomedicine and Lipid-Based Drug Delivery Systems: a Case Study to Better Understand Processes

(2020) Amrita Dikpati et al.   PHARMACEUTICAL RESEARCH

Pegfilgrastim (PEG-G-CSF) Induces Anti-polyethylene Glycol (PEG) IgM via a T Cell-Dependent Mechanism

(2020) Nehal E. Elsadek et al.   BIOLOGICAL & PHARMACEUTICAL BULLETIN

Nanoparticle Size Influences Antigen Retention and Presentation in Lymph Node Follicles for Humoral Immunity

(2019) Yi-Nan Zhang et al.   NANO LETTERS

mRNA vaccines — a new era in vaccinology

(2018) Norbert Pardi et al.   NATURE REVIEWS DRUG DISCOVERY

Anti-polyethylene glycol antibodies alter the protein corona deposited on nanoparticles and the physiological pathways regulating their fate in vivo

(2018) Philippe Grenier et al.   JOURNAL OF CONTROLLED RELEASE

Mechanistic understanding of in vivo protein corona formation on polymeric nanoparticles and impact on pharmacokinetics

(2017) Nicolas Bertrand et al.   Nature Communications

Analysis of Pre-existing IgG and IgM Antibodies against Polyethylene Glycol (PEG) in the General Population

(2016) Qi Yang et al.   ANALYTICAL CHEMISTRY

Measurement of Pre-Existing IgG and IgM Antibodies against Polyethylene Glycol in Healthy Individuals

(2016) Bing-Mae Chen et al.   ANALYTICAL CHEMISTRY

The Mystery of Antibodies Against Polyethylene Glycol (PEG) - What do we Know?

(2016) Christian Lubich et al.   PHARMACEUTICAL RESEARCH

BALB/c mice display more enhanced BCG vaccine induced Th1 and Th17 response than C57BL/6 mice but have equivalent protection

(2015) M. Carmen Garcia-Pelayo et al.   TUBERCULOSIS

Nanoparticles with photoinduced precipitation for the extraction of pollutants from water and soil

(2015) Ferdinand Brandl et al.   Nature Communications

Cancer nanotechnology: The impact of passive and active targeting in the era of modern cancer biology

(2013) Nicolas Bertrand et al.   ADVANCED DRUG DELIVERY REVIEWS

Intravenous Administration of Polyethylene Glycol-Coated (PEGylated) Proteins and PEGylated Adenovirus Elicits an Anti-PEG Immunoglobulin M Response

(2012) Taro Shimizu et al.   BIOLOGICAL & PHARMACEUTICAL BULLETIN

Antibodies against polyethylene glycol in healthy subjects and in patients treated with PEG-conjugated agents

(2012) Ricardo P Garay et al.   Expert Opinion on Drug Delivery

PEGylated PRINT Nanoparticles: The Impact of PEG Density on Protein Binding, Macrophage Association, Biodistribution, and Pharmacokinetics

(2012) Jillian L. Perry et al.   NANO LETTERS

Biomolecular coronas provide the biological identity of nanosized materials

(2012) Marco P. Monopoli et al.   Nature Nanotechnology

Accelerated Blood Clearance of PEGylated PLGA Nanoparticles Following Repeated Injections: Effects of Polymer Dose, PEG Coating, and Encapsulated Anticancer Drug

(2012) Roonak Saadati et al.   PHARMACEUTICAL RESEARCH

The journey of a drug-carrier in the body: An anatomo-physiological perspective

(2011) Nicolas Bertrand et al.   JOURNAL OF CONTROLLED RELEASE

Nanoparticle Size and Surface Chemistry Determine Serum Protein Adsorption and Macrophage Uptake

(2011) Carl D. Walkey et al.   JOURNAL OF THE AMERICAN CHEMICAL SOCIETY

T cell-independent B cell response is responsible for ABC phenomenon induced by repeated injection of PEGylated liposomes

(2010) Hiroyuki Koide et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

Complement: a key system for immune surveillance and homeostasis

(2010) Daniel Ricklin et al.   NATURE IMMUNOLOGY

Polymer–protein conjugates: an enzymatic activity perspective

(2010) Marc A. Gauthier et al.   Polymer Chemistry

Anti-PEG IgM Response against PEGylated Liposomes in Mice and Rats

(2010) Masako Ichihara et al.   Pharmaceutics

Effect of siRNA in PEG-coated siRNA-lipoplex on anti-PEG IgM production

(2009) Tatsuaki Tagami et al.   JOURNAL OF CONTROLLED RELEASE

Physicochemical Characterization and Study of in vitro Interactions of pH-sensitive Liposomes with the Complement System

(2008) Vildete A. S. Carmo et al.   JOURNAL OF LIPOSOME RESEARCH